Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|November 16, 2010
Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistryJoanna Begent, Neil J Sebire, Gill Levitt, et al.
Cancer Chemotherapy and Pharmacology|February 15, 2016
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimensGareth J Veal, Julie Errington, Jairam Sastry, et al.
Pharmaceutical Research|September 6, 2014
Iontophoretic transdermal sampling of iohexol as a non-invasive tool to assess glomerular filtration rateAsma Djabri, William van't Hoff, Penelope Brock, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL groupWalter Daniel Cacciavillano, Laurence Brugières, Margaret Childs, et al.
Pediatric Blood & Cancer|December 21, 2005
A case series of pediatric primary central nervous system lymphoma: favorable outcome without cranial irradiationOussama Abla, John T Sandlund, Lillian Sung, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2008
Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experienceMaretta De Ioris, Laurence Brugieres, Arthur Zimmermann, et al.
British Journal of Haematology|June 14, 2016
Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmesDaniel A Morgenstern, Gulrukh Ahsan, Margaret Brocklesby, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 11, 2024
Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastomaSalih Demir, Alina Hotes, Tanja Schmid, et al.
Cancer Research and Treatment|March 22, 2017
Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN StudyLoredana Amoroso, Giovanni Erminio, Guy Makin, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2012
Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL)József Zsíros, Laurence Brugières, Penelope Brock, et al.
Pageof 4